Nagasaki. If data from all 31 registries were used, this would have led to a large underestimation of national cancer incidence because of under-registration. The methods of registry selection, estimation of incidence and the limitations of these methods have been explained in previous studies (5 -7). As is mentioned in the last article, there were two major methodological changes in the MCIJ2003, and we maintained these changes in the present study: (i) we invited all 31 populationbased cancer registries in Japan to participate, and from these, we selected the 14 cancer registries with high-quality data in order to estimate the national incidence, and (ii) we used 2004 data alone for the national estimation. For this year, Kumamoto prefecture was newly selected as one of the registries with high-quality data for the national estimation, but the other registries remained since the previous estimations.
The Japan Cancer Surveillance Research Group is involved in cancer monitoring in Japan since 2000 (1 -4) . This group estimated the cancer incidence in 2004 as part of the Monitoring of Cancer Incidence in Japan (MCIJ) project, on the basis of data collected from 14 of 31 population-based cancer registries: Miyagi, Yamagata, Chiba, Kanagawa, Niigata, Fukui, Shiga, Osaka, Tottori, Okayama, Hiroshima, Saga, Kumamoto and Nagasaki. If data from all 31 registries were used, this would have led to a large underestimation of national cancer incidence because of under-registration. The methods of registry selection, estimation of incidence and the limitations of these methods have been explained in previous studies (5 -7) . As is mentioned in the last article, there were two major methodological changes in the MCIJ2003, and we maintained these changes in the present study: (i) we invited all 31 populationbased cancer registries in Japan to participate, and from these, we selected the 14 cancer registries with high-quality data in order to estimate the national incidence, and (ii) we used 2004 data alone for the national estimation. For this year, Kumamoto prefecture was newly selected as one of the registries with high-quality data for the national estimation, but the other registries remained since the previous estimations.
The number of incidences, crude rates, age-standardized rates and completeness of registration in 2004 are shown in Table 1 , and the age-specific number of incidences and the rates according to sex and primary site are shown in Tables 2 and 3 . The total number of incidences in Japan for 2004 was estimated as 623 275 (C00 -C96). The time trends of age-standardized incidence rates for the five major sites and male-and female-specific sites in 1975 -2004 are shown in Fig. 1 (standard population: the world population) and in Fig. 2 (standard population: the 1985 Japanese model population). The leading cancer site according to the crude and age-standardized incidence rates was the stomach for men and the breast for women, as shown in Figs 1 and 2. The apparent increase in age-standardized incidence rates in 2003 because of development of hospital-based cancer registry in designated cancer care hospitals was calmed down in 2004. The estimated cancer incidence data in Japan by sex, site, 5-year age group and calendar year during the period 1975 -2004 are available as a booklet and as an electronic database on the website (only available in Japanese, http://ganjoho.jp/ professional/statistics/monita.html). Per 100 000 population. Brain and nervous system C70-C72  2220  43  22  58  58  11  57  48  68  67  76  180  177  122  265  231  307  197  233   Thyroid  C73  7062  0  0  8  43  130  191  297  327  402  562  761  1155  762  815  602  459  277  271   Malignant  lymphoma   C81-C85,  C96   8063  8  30  21  40  29  117  101  107  247  292  540  720  889  930  1042  1020  929  1001   Multiple myeloma  C88, C90  2247  0  0  0  0  0  0  3  6  10  19  60  183  163  235  375  522  346  325   All leukemias  C91-C95  3726  91  34  36  74  35  83  60  113  104  162  163  251  364  456  367  515  385 433 
